[Inhibitory effect of various combinations of peplomycin, vincristine and ifosfamide against a hormone-independent human prostatic carcinoma cell line].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007069:Ifosfamide / Q000494:pharmacology*; D008297:Male; D017663:Peplomycin; D011471:Prostatic Neoplasms / Q000473:pathology*; D014750:Vincristine / Q000494:pharmacology*
D001761:Bleomycin; D017663:Peplomycin; D014750:Vincristine; D007069:Ifosfamide